J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cedillo-Barrón, L.
Right arrow Articles by Parkhouse, R. M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cedillo-Barrón, L.
Right arrow Articles by Parkhouse, R. M. E.
Agricola
Right arrow Articles by Cedillo-Barrón, L.
Right arrow Articles by Parkhouse, R. M. E.
Journal of General Virology (2001), 82, 1713-1724.
© 2001 Society for General Microbiology


Animal: RNA Viruses

Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase

Leticia Cedillo-Barrón1, Mildred Foster-Cuevasb,1, Graham J. Belsham1, François Lefèvre2 and R. Michael E. Parkhousec,1

Institute for Animal Health, Pirbright Laboratory, Pirbright, Surrey GU24 0NF, UK1
INRA Virology et Immunologie moléculaires, INRA, 78350 Jouy-en-josas, France2

Author for correspondence: Leticia Cedillo-Barrón. Present address: Centro de Investigacion y de Estudios Avanzados del IPN, Departamento de Biomedicina Molecular, Av. IPN #2508 Col. Zacatenco, 07360 México DF. Fax +52 5 747 7134. e-mail lcedillo{at}mail.cinvestav.mx

This work focuses on the development of a potential recombinant DNA vaccine against foot-and-mouth disease virus (FMDV). Such a vaccine would have significant advantages over the conventional inactivated virus vaccine, in particular having none of the risks associated with the high security requirements for working with live virus. The principal aim of this strategy was to stimulate an antibody response to native, neutralizing epitopes of empty FMDV capsids generated in vivo. Thus, a plasmid (pcDNA3.1/P1–2A3C3D) was constructed containing FMDV cDNA sequences encoding the viral structural protein precursor P1–2A and the non-structural proteins 3C and 3D. The 3C protein was included to ensure cleavage of the P1–2A precursor to VP0, VP1 and VP3, the components of self-assembling empty capsids. The non-structural protein 3D was also included in the construct in order to provide additional stimulation of CD4+ T cells. When swine were immunized with this plasmid, antibodies to FMDV and the 3D polymerase were synthesized. Furthermore, neutralizing antibodies were detected and, after three sequential vaccinations with DNA, some of the animals were protected against challenge with live virus. Additional experiments suggested that the antibody response to FMDV proteins was improved by the co-administration of a plasmid encoding porcine granulocyte–macrophage colony-stimulating factor. Although still not as effective as the conventional virus vaccine, the results encourage further work towards the development of a DNA vaccine against FMDV.




This article has been cited by other articles:


Home page
J. Virol.Home page
M. P. Moraes, T. de los Santos, M. Koster, T. Turecek, H. Wang, V. G. Andreyev, and M. J. Grubman
Enhanced Antiviral Activity against Foot-and-Mouth Disease Virus by a Combination of Type I and II Porcine Interferons
J. Virol., July 1, 2007; 81(13): 7124 - 7135.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. J. Grubman and B. Baxt
Foot-and-Mouth Disease
Clin. Microbiol. Rev., April 1, 2004; 17(2): 465 - 493.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. D. Kollnberger, B. Gutierrez-Castaneda, M. Foster-Cuevas, A. Corteyn, and R. M. E. Parkhouse
Identification of the principal serological immunodeterminants of African swine fever virus by screening a virus cDNA library with antibody
J. Gen. Virol., April 1, 2002; 83(6): 1331 - 1342.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2001 by the Society for General Microbiology.